Probiotics for Children with Coeliac Disease

Melissa_Peterson's picture

Probiotics modulate the immune response in children suffering from coeliac disease (CD) by reducing the pro- inflammatory cytokine tumour necrosis factor-alpha (TNF-alpha), according to a recent double-blind placebo-controlled trial. However, in this study the effects only lasted during active treatment, suggesting ongoing probiotic treatment may be required for children suffering immune-related gastrointestinal disorders.

As gluten can cause a dysregulated immune response leading to intestinal mucosal injury, intestinal permeability and malabsorption, CD is treated with a gluten free diet (GFD). However, studies have shown that gluten is not the only environmental factor in CD. The gut microbiota play a role in modulating the immune response through constant interplay with the mucosal immune system, and studies have shown that a dysbiotic gut may actually enhance the inflammatory response and damage caused by gluten.

In the recent study, 49 children on a GFD diet were randomised into two groups, with the treatment group receiving 2 billion CFUs of Bifidobacteria breve for three months. TNF-alpha levels were significantly reduced at the end of the intervention period, however levels increased again on follow-up, three months after treatment ceased, while still on the GFD. Therefore, a GFD diet alone only partially normalises the common imbalances of low Bifidobacterium spp. and high Bacteroides spp. seen in CD sufferers and may not modulate the inflammatory immune responses.[1]

These findings are supported in an earlier 2014 double-blind randomised placebo-controlled study in which Bifidobacterium longum (1 billion CFUs) given to 33 children on a GFD decreased peripheral CD3+ T lymphocytes and TNF-alpha levels. Additionally, it rebalanced gut microbiota composition by increasing bifidobacteria counts and reducing the potentially pathogenic and pro-inflammatory bacteria Bacteroides fragilis.[2]

Due to the disturbed microbiota composition of CD sufferers, the difficulty in adhering strictly to a GFD and the lack of a positive effect on TNF-alpha while only on the GFD, these studies suggest that successful treatment of CD may require constant probiotic therapy to modulate inappropriate immune responses and decrease gluten toxicity in children.

References

  1. Klemenak M, Dolinsek J, Langerholc T, et al. Administration of Bifidobacterium breve decreases the production of TNF-alpha in children with celiac disease. Dig Dis Sci 2015, July 2 [Epub ahead of print]. [Abstract]
     
  2. Olivares M, Castillejo G, Varea V, et al. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum cect 7347 in children with newly diagnosed coeliac disease. Br J Nutr 2014;112(1):30-40. [Full text]

DISCLAIMER: 

The information provided on FX Medicine is for educational and informational purposes only. The information provided on this site is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you have read here raises questions or concerns regarding your health. 

Share Research: 

SIGN UP TO OUR FREE eNEWS

Melissa_Peterson's picture
Melissa_Peterson

Melissa Peterson has been a writer and educator in the health and medical science fields for over 15 years. Naturopathically trained, Melissa also has postgraduate qualifications in literature research and reviewing. Her business, Words On Therapy, provides many services to industry including technical articles, white papers, blogs, SEO content, copywriting and research collation.